Cathartic-Free DECT Colonography for Detection of Colonic Polyps

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-02-28

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Asses the clinical performance of dual-energy CTC for the detection of larger polyps 1 cm or larger without cathartic preparation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps

NCT05179837

Colon Cancer Rectal Cancer Cancer of the Rectum +3 more

TERMINATED NA

Clinical Validation of Multimodal Digestive Endoscopy

NCT05575765

Colorectal Neoplasms Confocal Laser Endomicroscopy Endoscopy, Digestive System +1 more

SUSPENDED

Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies

NCT00874263

Colonic Polyps Esophageal Diseases

COMPLETED

Computer Assisted Optical Assessment of Small Colorectal Polyps

NCT02522702

Colonic Polyps

UNKNOWN

Detection and Classification of Colon Polyps

NCT00825292

Colon Polyps

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Determine the feasibility to differentiate polyps from stool with or without the use of contrast agents and to assess the feasibility and accuracy of dual energy techniques in a pilot patient study.

1.1 Formulate algorithms that use dual-energy information to quantitatively measure specific material density of colon polyps in physics based simulation.

1.2 Determine optimal scanning parameters on prototype CT equipment.

2.1 Measure the material composition density and Hounsfield number of polyps with and without simulated contrast enhancement.

2.2 Measure the accuracy of dual-energy techniques to differentiate between polyps and stool and if needed using a combination of simulated intravenous enhanced polyps and contrast material tagged stool.

3.0 Asses the clinical performance of dual-energy CTC for the detection of larger polyps 1 cm or larger without cathartic preparation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonic Polyps

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral Omnipaque MCA

Ten participant minimum: for stool tagging two days preceding the CT colonography, if applicable, with oral Omnipaque. This cohort at Scottsdale Mayo Clinic only.

No interventions assigned to this group

IV Iodine MCR

Ten participant minimum: for intravenous iodine contrast dye. This cohort at Rochester Mayo Clinic only.

No interventions assigned to this group

NO oral and no IV MCR

Five participant minimum for no oral or IV contrast.

No interventions assigned to this group

Replacement Group

Five participant minimum for either cohorts 1, 2, or 3 as above should there be poor imaging results. A like prepped participant will replace that who had poor quality imaging to meet 25 imaging data sets.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants with a known colorectal polyp or colon carcinoma with pathology, at or greater than 1 cm in size on a colonoscopy that is completed either eight weeks before or after CT Colonography study visit.
* If receiving iodine oral or IV contrast, must have a creatinine less than 1.4 on record within last 30 days of study visit date. If no creatinine is available, one will be drawn for enrollment criteria purposes.

Exclusion Criteria

* Pregnant females.
* Presence of colostomy or right hemicolectomy.
* Inflammatory bowel disease (Crohn's, chronic ulcerative colitis).
* Familial polyposis syndrome.
* Pregnant female.
* Creatinine at or greater than 1.4
* Severe or uncontrolled chronic obstructive pulmonary disease (COPD) or chronic obstructive lung disease (COLD).
* Iodine contrast allergy.

Minimum Eligible Age

40 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No